No shortage of HIV drug Dolutegravir: Mandaviya

Published on:

New Delhi, Aug 1 (IANS) Union Health and Family Welfare Minister Mansukh Mandaviya on Tuesday told the Parliament that there is no nation-wide shortage of HIV drug Dolutegravir.

His assurence came in response to a question in Rajya Sabha on whether there is a nation-wide shortage of the valuable HIV drug.

Dolutegravir (DTG) was introduced under the National AIDS Control Programme (NACP) in a phased manner in 2020, he said, adding that various proactive steps have been undertaken to ensure uninterrupted supply of antiretroviral (ARV) medicines including Dolutegravir.

In response to another question, Mandaviya said: “The MoHFW has developed a telemedicine application eSanjeevani, which provides doctor to doctor and patient to doctor consultations.

“This application works on a hub and spoke model wherein doctors including specialists provide services to patients in Health and Wellness Centers (HWCs) in rural areas. Further people in remote and rural areas can also avail services through OPD module of eSanjeevani.”

As on July 26 July, a total of 14,17,81,384 teleconsultations have been completed, Mandaviya added.



Disclaimer: Medical Science is an ever evolving field. We strive to keep this page updated. In case you notice any discrepancy in the content, please inform us at [email protected]. You can futher read our Correction Policy here. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website or it's social media channels. Read our Full Disclaimer Here for further information.

Except for the headline and photo, this story has not been edited by THIP Media staff and is published from a syndicated feed / newswire service.